Experience with PCSK9 inhibitors from a Nephrology unit

Nefrologia (Engl Ed). 2024 Jan-Feb;44(1):111-113. doi: 10.1016/j.nefroe.2024.02.007. Epub 2024 Feb 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticholesteremic Agents*
  • Nephrology*
  • PCSK9 Inhibitors
  • Proprotein Convertase 9

Substances

  • PCSK9 Inhibitors
  • PCSK9 protein, human
  • Proprotein Convertase 9
  • Anticholesteremic Agents